https://lucyrx.com/wp-content/uploads/2026/10/featured-image-3.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-10-22 14:27:012026-10-22 14:43:11What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?Guides & Toolkits

7 Strategic Levers to Take Control of GLP-1 Costs and Outcomes
GLP-1 drugs like Wegovy, Zepbound, Ozempic, and Mounjaro are transforming care—but without the right guardrails, costs can spiral.
Our GLP-1 Planning Checklist gives HR and Finance leaders 7 proven strategies to balance cost, access, and outcomes. Employers using these levers have achieved:
- 40% improvement in medication adherence
- 90% member satisfaction with the GLP-1 benefit
- Up to 54% cost savings and millions in healthcare savings
Don’t leave your GLP-1 strategy to chance.
Download the GLP-1 Planning Checklist to find high-impact changes that protect budgets and improve outcomes.
Don’t wait for costs to spiral—connect with us to model your savings potential.
We’ll review your plan, pinpoint cost levers, and show you how to balance member access with sustainable spend—fast.
Recommended Reads
https://lucyrx.com/wp-content/uploads/2026/10/featured-image-3.png
536
800
Kyrstin Hensley
/wp-content/uploads/2025/03/LucyRx-Logo-Primary.svg
Kyrstin Hensley2026-10-22 14:27:012026-10-22 14:43:11What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?
When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do
Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test
Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM
A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.

How Should a Specialty Pharmacy Earn Its Role?
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.

Disclosure Won. Now What?
PBM transparency gives employers greater visibility into pharmacy costs—but disclosure is only the beginning. Learn how plan sponsors can turn better information into greater control, accountability, and measurable results.

What Makes a Pharmacy Benefit Solution Easier for TPAs to Stand Behind?
Third-party administrators put their own client relationships at stake when recommending a pharmacy benefit manager. Learn which capabilities help TPAs evaluate PBM partners, explain benefit strategies confidently and maintain accountability from implementation through renewal.

When Women’s Health Reaches the Prescription, the Pharmacy Benefit Still Has Work to Do
Women’s health programs can improve clinical access, but prescription barriers can still interrupt treatment. Employers and benefits leaders should evaluate affordability, coverage, medication availability and how quickly access problems are resolved.

PBM Flexibility Is Not the Same as Control: What TPAs Should Test
Pharmacy benefit options have limited value if contract restrictions or operational barriers prevent employers from using them. This article outlines how TPAs can assess decision-making information, contractual rights and implementation capabilities before recommending a PBM.

Implementation Is Part of the Sale: What TPAs Should Test Before Recommending a PBM
A PBM transition can put a TPA’s client relationship at risk if eligibility errors, prescription disruptions or unclear responsibilities emerge at go-live. This checklist outlines five areas TPAs should test before recommending a PBM to an employer.

How Should a Specialty Pharmacy Earn Its Role?
Specialty pharmacy can materially affect employer plan costs, access, and treatment continuity. This article outlines the measures benefits leaders can use to evaluate pharmacy channels based on evidence rather than affiliation.

Projected Savings vs. Realized Savings: What Employers Should Ask
Employers need to know whether a pharmacy savings figure represents an opportunity or an actual result. This article explains how to evaluate savings methodology, assumptions, and outcomes.

A Better Way to Think About GLP-1 Strategy
GLP-1 coverage no longer has to be an all-or-nothing decision. Employers can evaluate access, clinical support, costs, and benefit visibility to build a strategy that works for their plan and the people who rely on it.

Diabetes Affordability is About More Than One Prescription
Diabetes affordability extends beyond insulin. Learn how employers can evaluate medication costs, GLP-1s, monitoring devices, coverage rules, and member support across the full diabetes regimen.

Is Your Pharmacy Benefit Still Working as Intended?
A pharmacy benefit can perform as designed and still fall behind the market. Learn how employers can evaluate costs, member access, plan design, and PBM performance—and decide whether to stay, improve the current strategy, or explore a change.


Share